Charles E. Murry

Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting.

In vitro generation of differentiated cardiac myofibers on micropatterned laminin surfaces.

Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts.

Taking the death toll after cardiomyocyte grafting: a reminder of the importance of quantitative biology.

Muscle cell grafting for the treatment and prevention of heart failure.

Cell grafting for cardiac repair.

Intracoronary E-/L-selectin blockade reduces neutrophil infiltration in heart transplantation.

Skeletal muscle meets cardiac muscle. Friends or foes?

Immunohistologic labeling of murine endothelium.

Spatially organized layers of cardiomyocytes on biodegradable polyurethane films for myocardial repair.

Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair.

Evidence for fusion between cardiac and skeletal muscle cells.

Myogenic fusion of human bone marrow stromal cells, but not hematopoietic cells.

Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts.

NFATc3-induced reductions in voltage-gated K+ currents after myocardial infarction.

Gene transfer of connexin43 into skeletal muscle.

Regenerating the heart.

Formation of human myocardium in the rat heart from human embryonic stem cells.

Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/Akt signaling pathway.

Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart.

Cell-based cardiac repair: reflections at the 10-year point.

Regeneration gaps: observations on stem cells and cardiac repair.

rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice.

Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response.

Chemical dimerization of fibroblast growth factor receptor-1 induces myoblast proliferation, increases intracardiac graft size, and reduces ventricular dilation in infarcted hearts.

Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells.

Selective control of endothelial cell proliferation with a synthetic dimerizer of FGF receptor-1.

Cardiac aid to the injured but not the elderly?

Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts.

Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular function.

Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms.

Absence of regeneration in the MRL/MpJ mouse heart following infarction or cryoinjury.

Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development.

Retention and biodistribution of microspheres injected into ischemic myocardium.

Chromatin remodeling during mouse and human embryonic stem cell differentiation.

Bones of contention: marrow-derived cells in myocardial regeneration.

A hierarchical network controls protein translation during murine embryonic stem cell self-renewal and differentiation.

Systems approaches to preventing transplanted cell death in cardiac repair.

Get with the (re)program: cardiovascular potential of skin-derived induced pluripotent stem cells.

Scaffold-free human cardiac tissue patch created from embryonic stem cells.

Development biology. Turnover after the fallout.

Cell therapy enhances function of remote non-infarcted myocardium.

Myostatin represses physiological hypertrophy of the heart and excitation-contraction coupling.

VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering.

Taking a load off: nuclear remodeling after mechanically supporting the failing human heart.

The role of macrophage-derived urokinase plasminogen activator in myocardial infarct repair: urokinase attenuates ventricular remodeling.

Endogenous Wnt/beta-catenin signaling is required for cardiac differentiation in human embryonic stem cells.

Differentiation of cardiomyocytes from human embryonic stem cells is accompanied by changes in the extracellular matrix production of versican and hyaluronan.

Ferritin overexpression for noninvasive magnetic resonance imaging-based tracking of stem cells transplanted into the heart.

Proangiogenic scaffolds as functional templates for cardiac tissue engineering.

Cardiogenesis from human embryonic stem cells.

Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium.

Developing vasculature and stroma in engineered human myocardium.

Reprogramming fibroblasts into cardiomyocytes.

Engineered human cardiac tissue.

A repair "kit" for the infarcted heart.

Heart regeneration.

Growth of engineered human myocardium with mechanical loading and vascular coculture.

Evidence that gene activation and silencing during stem cell differentiation requires a transcriptionally paused intermediate state.

Upregulation of cardiomyocyte ribonucleotide reductase increases intracellular 2 deoxy-ATP, contractility, and relaxation.

Synthetic matrices to serve as niches for muscle cell transplantation.

Truncations of titin causing dilated cardiomyopathy.